<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04989114</url>
  </required_header>
  <id_info>
    <org_study_id>704/RC/KEMU</org_study_id>
    <nct_id>NCT04989114</nct_id>
  </id_info>
  <brief_title>Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis</brief_title>
  <official_title>Effectiveness of Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Comparison to Standard Care in Children With Bronchiolitis: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ameer asadullah gull</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Edward Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King Edward Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to assess the effectiveness of nasal continuous positive airway&#xD;
      pressure in reducing respiratory distress in children with bronchiolitis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, after taking consent from caretakers, patients of brochiolitis will be&#xD;
      randomly assigned to either a standard care group or a nasal continuous positive airway&#xD;
      pressure group. Both groups will be followed for respiratory distress. Respiratory distress&#xD;
      will be compared by using Seattle sore of respiratory distress.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 6, 2020</start_date>
  <completion_date type="Anticipated">September 5, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 5, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction in seattle score</measure>
    <time_frame>after 12 hours</time_frame>
    <description>seattle score will be noted and compared for both groups</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Bronchiolitis Acute Viral</condition>
  <condition>Bronchiolitis</condition>
  <condition>Bronchiolitis Acute</condition>
  <condition>Bronchiolitis, Viral</condition>
  <condition>Nasal Continuous Positive Airway Pressure</condition>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In this arm, oxygen inhalation will be provided without positive end expiratory pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nasal continuous positive airway pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this arm, positive end expiratory pressure will be provided by nasal continuous positive airway pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nasal continuous positive airway pressure</intervention_name>
    <description>positive end expiratory pressure will be applied by nasal continuous positive airway pressure</description>
    <arm_group_label>nasal continuous positive airway pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children presenting with history of cough, and tachypnea and wheezing on clinical&#xD;
             examination&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients needing mechanical ventilation at the time of admission&#xD;
&#xD;
          -  Patients whose caretakers refuse written informed consent&#xD;
&#xD;
          -  Patients having consolidation on chest X-Ray&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muhammad Haroon Hamid, MBBSFCPSFRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Edward Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ameer Asadullah Gull, MBBS</last_name>
    <phone>00923084860184</phone>
    <email>hellowgull@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Muhammad Haroon Hamid, MBBSFCPSFRCS</last_name>
    <phone>00923008880916</phone>
    <email>haroonr5@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Hospital</name>
      <address>
        <city>Lahore</city>
        <state>Punjab</state>
        <zip>54000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ameer Asadullah Gull, MBBS</last_name>
      <phone>00923084860184</phone>
      <email>hellowgull@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Muhammad Haroon Hamid, MBBSFCPSFRCS</last_name>
      <phone>00923008880919</phone>
      <email>haroonr5@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2021</study_first_posted>
  <last_update_submitted>July 24, 2021</last_update_submitted>
  <last_update_submitted_qc>July 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>King Edward Medical University</investigator_affiliation>
    <investigator_full_name>ameer asadullah gull</investigator_full_name>
    <investigator_title>Postgraduate Resident Pediatric Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Bronchiolitis, Viral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

